Arix Bioscience Plc Sir John Banham retires from Board of Directors (1565W)
November 10 2017 - 3:00AM
UK Regulatory
TIDMARIX
RNS Number : 1565W
Arix Bioscience Plc
10 November 2017
Sir John Banham retires from Board of Directors of Arix
Bioscience plc
LONDON, 10 November 2017: Arix Bioscience plc (LSE: ARIX) ("Arix
Bioscience" or "the Company"), a global healthcare and life science
company supporting medical innovation, today announces that Sir
John Banham is retiring from his position as a Non-Executive
Director of Arix Bioscience.
Sir John, who is 76, has been Chairman of the Audit and Risk
Committee, and has helped to oversee the Company's growth both as a
private company and since its successful IPO on the London Stock
Exchange in February 2017. As previously announced, Giles Kerr
joined the Board of Arix on 17 October 2017 and will succeed Sir
John as Chairman of the Audit and Risk Committee.
Jonathan Peacock, Chairman of Arix Bioscience, said: "It has
been a pleasure and a privilege to work with Sir John. On behalf of
the Board, I would like to thank him for his many contributions to
the successful creation and early development of Arix
Bioscience."
For more information, please contact:
Arix Bioscience plc
Matthew Cole, Communications Director
+44 (0) 20 7290 1065
Consilium Strategic Communications
Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan
+44 (0)20 3709 5700
arix@consilium-comms.com
About Arix Bioscience plc
Arix Bioscience plc is a global healthcare and life science
company supporting medical innovation. Headquartered in London and
with an office in New York, Arix Bioscience sources, finances and
builds world class healthcare and life science businesses
addressing medical innovation at all stages of development.
Operations are supported by privileged access to breakthrough
academic science and strategic relationships with leading research
accelerators and global pharmaceutical companies.
Arix Bioscience plc is listed on the Main Market of the London
Stock Exchange. For further information, please visit
www.arixbioscience.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAGIBDBISBBGRG
(END) Dow Jones Newswires
November 10, 2017 04:00 ET (09:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2024 to May 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From May 2023 to May 2024